Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: Population based cohort study

British Medical Journal

Volumn 335, Issue 7627, 2007, Pages 978-981

  Magnussen, Elisabeth Balstad ^a,b   Vatten, Lars Johan ^a   Lund Nilsen, Tom Ivar ^a   Salvesen, Kjell Åsmund ^b,c   Smith, George Davey ^d   Romundstad, Pål Richard ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIRTH; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NORWAY; NULLIPARA; PARITY; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; NORWAY; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 36348945130     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39366.416817.BE     Document Type: Article

References (27)

1. Rodie VA, Freeman DJ, Sattar N, Greer IA. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004;175:189-202.
2. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403-8.
3. Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J, et al. Lipoprotein subfraction changes in normal pregnancy. J Clin Endocrinol Metab 1997;82:2483-91.
4. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for preeclampsia. Br J Obstet Gynaecol 2006;113:379-86.
5. Holmen J, Midthjell K, Kruger Ø, Langhammer A, Lingaas Holmen T, Bratberg GH, et al. The Nord-Trøndelag health study 1995-97 (HUNT 2). Norsk Epidemiol 2003;13:19-32.
6. Irgens LM. The medical birth registry of Norway. Epidemiolgical research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000;79:435-9.
7. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
8. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med 2000;15:395-9.
9. Ness RB, Markovic N, Bass D, Harger G, Roberts JM. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003;102:1366-71.
10. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845.
11. Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, Dempsey JC, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003;41:408-13.
12. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999;181:1026-35.
13. Salafia C, Shiverick K. Cigarette smoking and pregnancy II: vascular effects. Placenta 1999;20:273-9.
14. Thadhani R, Stampfer MJ, Chasan-Taber L, Willett WC, Curhan GC. A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy. Contraception 1999;60:145-50.
15. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med 2002;346:33-8.
16. Sibai B, Dekker G, Kupfermine M. Preeclampsia. Lancet 2005;365:785-99.
17. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Br J Obstet Gynaecol 2001;108:1081-7.
18. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? Br J Obstet Gynaecol 2004;111:298-302.
19. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007;18:234-9.
20. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-60.
21. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001;323:1213-7.
22. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366:1797-803.
23. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6.
24. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
25. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40-9.
26. Goode GK, Miller JP, Heagerty HM. Hyperlipidaemia, hypertension and coronary heart disease. Lancet 1995;345:362-4.
27. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648-55.